NCT02104882View on ClinicalTrials.gov

INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Glioblastoma Multiforme
Interventions
RADIATION

Intraoperative Radiotherapy (Applicator Surface Dose: 20-40 Gy)

Trial Locations (1)

68167

Universitätsmedizin Mannheim, University of Heidelberg, Mannheim

All Listed Sponsors
lead

Universitätsmedizin Mannheim

OTHER

NCT02104882 - INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study | Biotech Hunter | Biotech Hunter